Mufg Securities Americas Inc. Has $1.63 Million Stock Holdings in Cencora, Inc. $COR

Mufg Securities Americas Inc. raised its stake in Cencora, Inc. (NYSE:COR) by 36.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,229 shares of the company’s stock after purchasing an additional 1,406 shares during the period. Mufg Securities Americas Inc.’s holdings in Cencora were worth $1,634,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in COR. Vermillion & White Wealth Management Group LLC grew its stake in shares of Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the period. Cloud Capital Management LLC acquired a new position in Cencora during the 3rd quarter worth approximately $31,000. Westside Investment Management Inc. boosted its holdings in Cencora by 200.0% in the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after acquiring an additional 70 shares in the last quarter. Copia Wealth Management grew its stake in Cencora by 505.0% in the third quarter. Copia Wealth Management now owns 121 shares of the company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. Finally, Caldwell Trust Co acquired a new stake in Cencora in the second quarter valued at approximately $46,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Trading Down 0.3%

NYSE:COR opened at $364.80 on Wednesday. Cencora, Inc. has a 52 week low of $244.97 and a 52 week high of $377.54. The firm has a 50-day moving average price of $350.19 and a two-hundred day moving average price of $332.57. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. The firm has a market cap of $70.96 billion, a price-to-earnings ratio of 43.85, a price-to-earnings-growth ratio of 1.71 and a beta of 0.68.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.73 EPS. On average, equities analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, February 13th. Cencora’s dividend payout ratio is 28.85%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Wall Street Zen lowered Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Robert W. Baird set a $415.00 price objective on shares of Cencora in a report on Tuesday, January 13th. TD Cowen raised their price objective on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research note on Monday, November 10th. JPMorgan Chase & Co. boosted their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Finally, Wells Fargo & Company raised their price target on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Eleven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $399.00.

Insider Activity

In related news, EVP Silvana Battaglia sold 1,677 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $345.00, for a total transaction of $578,565.00. Following the completion of the sale, the executive vice president owned 18,796 shares in the company, valued at approximately $6,484,620. This trade represents a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the sale, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. This represents a 7.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,220 shares of company stock valued at $5,282,867 in the last ninety days. 0.38% of the stock is currently owned by insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.